A.D. Beadell Investment Counsel’s Sanofi SNY Stock Holding History

A.D. Beadell Investment Counsel’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-15,825	Closed	-$716K	–	91
2017 Q1	$716K	Hold	15,825	–	–	0.59%	54
2016 Q4	$639K	Hold	15,825	–	–	0.55%	59
2016 Q3	$604K	Buy	15,825 +315	+2%	+$12.6K	0.5%	62
2016 Q2	$649K	Hold	15,510	–	–	0.53%	64
2016 Q1	$622K	Buy	15,510 +850	+6%	+$34.1K	0.57%	61
2015 Q4	$625K	Buy	14,660 +4,025	+38%	+$185K	0.55%	63
2015 Q3	$504K	Hold	10,635	–	–	0.46%	67
2015 Q2	$526K	Hold	10,635	–	–	0.42%	72
2015 Q1	$525K	Buy	10,635 +1,500	+16%	+$71.7K	0.41%	74
2014 Q4	$416K	Buy	+9,135	New	+$443K	0.32%	85

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

A.D. Beadell Investment Counsel's SNY Position: Q2 2017 in Review

A.D. Beadell Investment Counsel sold out of Sanofi (SNY) in Q2 2017, closing a stake of 15,825 shares — an estimated $716K sold.

A.D. Beadell Investment Counsel first reported a position in SNY in Q4 2014 and held it in 10 quarters. The position peaked at $716K in Q1 2017. 474 funds tracked by Wall St. Rank hold SNY as of Q2 2017.

A.D. Beadell Investment Counsel reported no remaining Sanofi position as of Q2 2017 after selling out during the quarter.
A.D. Beadell Investment Counsel sold 15,825 Sanofi shares in Q2 2017, an estimated $716K.
A.D. Beadell Investment Counsel first reported a position in Sanofi in Q4 2014 and held it in 10 quarters.
A.D. Beadell Investment Counsel's Sanofi position peaked at $716K in Q1 2017.
474 funds tracked by Wall St. Rank held Sanofi as of Q2 2017.

Based on A.D. Beadell Investment Counsel's 13F filing for Q2 2017, filed 25 Jul 2017.